116 related articles for article (PubMed ID: 8170137)
1. The natural history of bacterial biofilm graft infection.
Bergamini TM; Corpus RA; Brittian KR; Peyton JC; Cheadle WG
J Surg Res; 1994 May; 56(5):393-6. PubMed ID: 8170137
[TBL] [Abstract][Full Text] [Related]
2. Infection of vascular prostheses caused by bacterial biofilms.
Bergamini TM; Bandyk DF; Govostis D; Kaebnick HW; Towne JB
J Vasc Surg; 1988 Jan; 7(1):21-30. PubMed ID: 2961893
[TBL] [Abstract][Full Text] [Related]
3. Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques.
Bergamini TM; Bandyk DF; Govostis D; Vetsch R; Towne JB
J Vasc Surg; 1989 May; 9(5):665-70. PubMed ID: 2524605
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus epidermidis graft infection is associated with locally suppressed major histocompatibility complex class II and elevated MAC-1 expression.
Henke PK; Bergamini TM; Garrison JR; Brittian KR; Peyton JC; Lam TM
Arch Surg; 1997 Aug; 132(8):894-902. PubMed ID: 9267276
[TBL] [Abstract][Full Text] [Related]
5. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
[TBL] [Abstract][Full Text] [Related]
6. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression augments growth of graft-adherent Staphylococcus epidermidis.
Bergamini TM; Corpus RA; McCurry TM; Peyton JC; Brittian KR; Cheadle WG
Arch Surg; 1995 Dec; 130(12):1345-50. PubMed ID: 7492284
[TBL] [Abstract][Full Text] [Related]
8. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model.
Muhl E; Gatermann S; Iven H; Dendorfer A; Bruch HP
Ann Vasc Surg; 1996 May; 10(3):244-53. PubMed ID: 8792993
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic antibiotics prevent bacterial biofilm graft infection.
Bergamini TM; Peyton JC; Cheadle WG
J Surg Res; 1992 Feb; 52(2):101-5. PubMed ID: 1346815
[TBL] [Abstract][Full Text] [Related]
10. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron.
Sardelic F; Ao PY; Taylor DA; Fletcher JP
Cardiovasc Surg; 1996 Jun; 4(3):389-92. PubMed ID: 8782944
[TBL] [Abstract][Full Text] [Related]
12. In situ replacement of vascular prostheses infected by bacterial biofilms.
Bandyk DF; Bergamini TM; Kinney EV; Seabrook GR; Towne JB
J Vasc Surg; 1991 May; 13(5):575-83. PubMed ID: 2027196
[TBL] [Abstract][Full Text] [Related]
13. Anastomotic tensile strength following in situ replacement of an infected abdominal aortic graft.
Vetsch R; Bandyk DF; Schmitt DD; Bergamini TM; Storey JD; Towne JB
Arch Surg; 1989 Apr; 124(4):425-8. PubMed ID: 2522764
[TBL] [Abstract][Full Text] [Related]
14. [Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model].
Hernández-Richter T; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Wichmann M; Heiss MM; Schardey HM; Angele MK
Zentralbl Chir; 2003 Mar; 128(3):244-9. PubMed ID: 12739511
[TBL] [Abstract][Full Text] [Related]
15. Treatment of bacteria-biofilm graft infection by in situ replacement in normal and immune-deficient states.
Bandyk DF; Kinney EV; Riefsnyder TI; Kelly H; Towne JB
J Vasc Surg; 1993 Sep; 18(3):398-405; discussion 405-6. PubMed ID: 8104253
[TBL] [Abstract][Full Text] [Related]
16. In situ replacement of arterial prosthesis infected by bacterial biofilms: long-term follow-up.
Towne JB; Seabrook GR; Bandyk D; Freischlag JA; Edmiston CE
J Vasc Surg; 1994 Feb; 19(2):226-33; discussion 233-5. PubMed ID: 8114184
[TBL] [Abstract][Full Text] [Related]
17. Development of a Staphylococcus epidermidis vascular graft infection model in sheep.
Sardelic F; Peng YA; Fletcher JP
Aust N Z J Surg; 1995 Jul; 65(7):503-6. PubMed ID: 7611972
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of a triple antimicrobial-bonded Dacron graft for the prevention of aortic graft infection.
Aboshady I; Raad I; Shah AS; Vela D; Dvorak T; Safi HJ; Buja LM; Khalil KG
J Vasc Surg; 2012 Sep; 56(3):794-801. PubMed ID: 22579134
[TBL] [Abstract][Full Text] [Related]
19. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts.
Gahtan V; Esses GE; Bandyk DF; Nelson RT; Dupont E; Mills JL
J Surg Res; 1995 Jan; 58(1):105-10. PubMed ID: 7830398
[TBL] [Abstract][Full Text] [Related]
20. Laser-induced shock waves enhance sterilization of infected vascular prosthetic grafts.
Nigri GR; Tsai S; Kossodo S; Waterman P; Fungaloi P; Hooper DC; Doukas AG; LaMuraglia GM
Lasers Surg Med; 2001; 29(5):448-54. PubMed ID: 11891733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
